Fennec Pharmaceuticals Inc. (TSX:FRX)
Canada flag Canada · Delayed Price · Currency is CAD
15.04
-0.25 (-1.64%)
Sep 24, 2026, 3:56 PM EST

Fennec Pharmaceuticals Statistics

Total Valuation

TSX:FRX has a market cap or net worth of CAD 526.88 million. The enterprise value is 468.52 million.

Market Cap526.88M
Enterprise Value 468.52M

Important Dates

The next estimated earnings date is Thursday, November 12, 2026.

Earnings Date Nov 12, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 35.07M
Shares Outstanding n/a
Shares Change (YoY) +16.69%
Shares Change (QoQ) +2.48%
Owned by Insiders (%) 2.91%
Owned by Institutions (%) 25.32%
Float 19.88M

Valuation Ratios

PE Ratio n/a
Forward PE 23.26
PS Ratio 6.26
PB Ratio 8.74
P/TBV Ratio 8.74
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 5.59
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.85

Current Ratio 5.85
Quick Ratio 5.21
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1.19

Financial Efficiency

Return on equity (ROE) is -18.58% and return on invested capital (ROIC) is -2.59%.

Return on Equity (ROE) -18.58%
Return on Assets (ROA) -1.16%
Return on Invested Capital (ROIC) -2.59%
Return on Capital Employed (ROCE) -1.77%
Weighted Average Cost of Capital (WACC) 10.30%
Revenue Per Employee 2.40M
Profits Per Employee -131,866
Employee Count35
Asset Turnover 0.98
Inventory Turnover 1.62

Taxes

In the past 12 months, TSX:FRX has paid 210,175 in taxes.

Income Tax 210,175
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +28.22% in the last 52 weeks. The beta is 1.10, so TSX:FRX's price volatility has been similar to the market average.

Beta (5Y) 1.10
52-Week Price Change +28.22%
50-Day Moving Average 14.79
200-Day Moving Average 12.07
Relative Strength Index (RSI) 47.90
Average Volume (20 Days) 1,101

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 2.52

Income Statement

In the last 12 months, TSX:FRX had revenue of CAD 84.10 million and -4.62 million in losses. Loss per share was -0.14.

Revenue84.10M
Gross Profit 78.82M
Operating Income -1.60M
Pretax Income -4.41M
Net Income -4.62M
EBITDA -1.45M
EBIT -1.60M
Loss Per Share -0.14
Full Income Statement

Balance Sheet

The company has 58.58 million in cash and no debt, with a net cash position of 58.58 million.

Cash & Cash Equivalents 58.58M
Total Debt n/a
Net Cash 58.58M
Net Cash Per Share n/a
Equity (Book Value) 60.27M
Book Value Per Share 1.72
Working Capital 85.36M
Full Balance Sheet

Cash Flow

Operating Cash Flow -2.89M
Capital Expenditures n/a
Depreciation & Amortization 145,248
Net Borrowing -27.56M
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 93.73%, with operating and profit margins of -1.90% and -5.49%.

Gross Margin 93.73%
Operating Margin -1.90%
Pretax Margin -5.24%
Profit Margin -5.49%
EBITDA Margin -1.72%
EBIT Margin -1.90%
FCF Margin n/a

Dividends & Yields

TSX:FRX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -16.69%
Shareholder Yield -16.69%
Earnings Yield -0.88%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on September 5, 2014. It was a reverse split with a ratio of 0.3333333.

Last Split Date Sep 5, 2014
Split Type Reverse
Split Ratio 0.3333333

Scores

TSX:FRX has an Altman Z-Score of 2.16 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.16
Piotroski F-Score 4